The estimated Net Worth of Susan E. Barrowcliffe is at least $1.4 Milion dollars as of 19 November 2018. Susan Barrowcliffe owns over 40,000 units of Aimmune Therapeutics Inc stock worth over $1,402,250 and over the last 9 years Susan sold AIMT stock worth over $0.
Susan has made over 9 trades of the Aimmune Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Susan exercised 40,000 units of AIMT stock worth $120,800 on 19 November 2018.
The largest trade Susan's ever made was exercising 75,000 units of Aimmune Therapeutics Inc stock on 2 January 2018 worth over $226,500. On average, Susan trades about 16,154 units every 57 days since 2016. As of 19 November 2018 Susan still owns at least 49,375 units of Aimmune Therapeutics Inc stock.
You can see the complete history of Susan Barrowcliffe stock trades at the bottom of the page.
Susan's mailing address filed with the SEC is 8000 Marina Blvd #200, Brisbane, CA 94005, USA.
Over the last 9 years, insiders at Aimmune Therapeutics Inc have traded over $19,285,948 worth of Aimmune Therapeutics Inc stock and bought 61,698,079 units worth $2,225,231,200 . The most active insiders traders include Des Produits Nestle S.A. So..., Patrick G Enright oraz Des Produits Nestle S.A.Nes.... On average, Aimmune Therapeutics Inc executives and independent directors trade stock every 22 days with the average trade being worth of $21,038,606. The most recent stock trade was executed by Des Produits Nestle S.A. So... on 13 October 2020, trading 54,117,287 units of AIMT stock currently worth $1,867,046,402.
Aimmune Therapeutics Inc executives and other stock owners filed with the SEC include: